annual ROE:
-60.44%+420.91%(+87.44%)Summary
- As of today (September 17, 2025), AVDL annual return on equity is -60.44%, with the most recent change of +420.91% (+87.44%) on December 31, 2024.
- During the last 3 years, AVDL annual ROE has risen by +3.86% (+6.00%).
- AVDL annual ROE is now -153.12% below its all-time high of 113.79%, reached on December 31, 2019.
Performance
AVDL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-3.81%+31.76%(+89.29%)Summary
- As of today (September 17, 2025), AVDL quarterly return on equity is -3.81%, with the most recent change of +31.76% (+89.29%) on June 1, 2025.
- Over the past year, AVDL quarterly ROE has increased by +104.64% (+96.49%).
- AVDL quarterly ROE is now -100.50% below its all-time high of 755.56%, reached on March 31, 2023.
Performance
AVDL quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVDL ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +87.4% | +96.5% |
3 y3 years | +6.0% | +98.0% |
5 y5 years | -153.1% | -105.8% |
AVDL ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +87.5% | -100.5% | +99.6% |
5 y | 5-year | -153.1% | +87.5% | -100.5% | +99.6% |
alltime | all time | -153.1% | +94.8% | -100.5% | +99.9% |
AVDL ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | -3.81%(-89.3%) |
Mar 2025 | - | -35.57%(-43.9%) |
Dec 2024 | -60.44%(-87.4%) | -63.43%(-26.4%) |
Sep 2024 | - | -86.15%(-20.6%) |
Jun 2024 | - | -108.45%(-47.3%) |
Mar 2024 | - | -205.66%(-27.7%) |
Dec 2023 | -481.35%(-0.0%) | -284.41%(-35.0%) |
Sep 2023 | - | -437.63%(-58.3%) |
Jun 2023 | - | -1048.41%(-238.8%) |
Mar 2023 | - | 755.56%(-206.1%) |
Dec 2022 | -481.49%(+648.8%) | -711.81%(+133.1%) |
Sep 2022 | - | -305.35%(+58.4%) |
Jun 2022 | - | -192.79%(+108.3%) |
Mar 2022 | - | -92.56%(+42.4%) |
Dec 2021 | -64.30%(-708.9%) | -65.00%(+34.9%) |
Sep 2021 | - | -48.20%(+32.7%) |
Jun 2021 | - | -36.32%(+794.6%) |
Mar 2021 | - | -4.06%(-159.9%) |
Dec 2020 | 10.56%(-90.7%) | 6.78%(-71.3%) |
Sep 2020 | - | 23.64%(-64.0%) |
Jun 2020 | - | 65.62%(-67.4%) |
Mar 2020 | - | 201.31%(+26.5%) |
Dec 2019 | 113.79%(-152.7%) | 159.13%(-104.8%) |
Sep 2019 | - | -3322.04%(+685.5%) |
Jun 2019 | - | -422.91%(+97.7%) |
Mar 2019 | - | -213.96%(+43.5%) |
Dec 2018 | -215.72%(-301.7%) | -149.05%(+202.7%) |
Sep 2018 | - | -49.24%(+1182.3%) |
Jun 2018 | - | -3.84%(-110.7%) |
Mar 2018 | - | 35.94%(-61.5%) |
Dec 2017 | 106.97%(-244.1%) | 93.43%(-28.4%) |
Sep 2017 | - | 130.55%(+75.4%) |
Jun 2017 | - | 74.43%(-514.0%) |
Mar 2017 | - | -17.98%(-76.7%) |
Dec 2016 | -74.24%(-183.5%) | -77.12%(-244.5%) |
Sep 2016 | - | 53.36%(+64.6%) |
Jun 2016 | - | 32.42%(-24.8%) |
Mar 2016 | - | 43.09%(-59.4%) |
Dec 2015 | 88.90%(-107.7%) | 106.06%(-145.8%) |
Sep 2015 | - | -231.64%(+76.2%) |
Jun 2015 | - | -131.49%(+14.3%) |
Mar 2015 | - | -115.06%(-51.0%) |
Dec 2014 | -1156.13%(+160.9%) | -234.73%(+27.8%) |
Sep 2014 | - | -183.65%(-28.4%) |
Jun 2014 | - | -256.56%(-47.7%) |
Mar 2014 | - | -490.61%(-63.0%) |
Dec 2013 | -443.11%(+4037.3%) | -1324.61%(+127.1%) |
Sep 2013 | - | -583.15%(+152.2%) |
Jun 2013 | - | -231.20%(+424.6%) |
Mar 2013 | - | -44.07%(+301.4%) |
Dec 2012 | -10.71%(-59.7%) | -10.98%(-77.3%) |
Sep 2012 | - | -48.27%(+132.3%) |
Jun 2012 | - | -20.78%(+73.5%) |
Mar 2012 | - | -11.98%(-55.1%) |
Dec 2011 | -26.55%(+20.1%) | -26.69%(+123.9%) |
Sep 2011 | - | -11.92%(-55.3%) |
Jun 2011 | - | -26.67%(-6.6%) |
Mar 2011 | - | -28.55%(+21.5%) |
Dec 2010 | -22.11% | -23.49%(-47.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | -44.30%(+41.9%) |
Jun 2010 | - | -31.23%(+44.1%) |
Mar 2010 | - | -21.67%(+70.6%) |
Dec 2009 | -24.49%(+4.6%) | -12.70%(-71.2%) |
Sep 2009 | - | -44.17%(-9.7%) |
Jun 2009 | - | -48.91%(-12.4%) |
Mar 2009 | - | -55.83%(-12.0%) |
Dec 2008 | -23.42%(-60.4%) | -63.44%(+134.1%) |
Sep 2008 | - | -27.10%(-29.3%) |
Jun 2008 | - | -38.34%(-28.7%) |
Mar 2008 | - | -53.79%(-10.4%) |
Dec 2007 | -59.12%(+34.1%) | -60.06%(+1.9%) |
Sep 2007 | - | -58.96%(+6.2%) |
Jun 2007 | - | -55.50%(+21.5%) |
Mar 2007 | - | -45.69%(+4.3%) |
Dec 2006 | -44.09%(+63.8%) | -43.79%(+4.9%) |
Sep 2006 | - | -41.73%(-0.1%) |
Jun 2006 | - | -41.79%(+9.1%) |
Mar 2006 | - | -38.32%(+45.6%) |
Dec 2005 | -26.92%(-324.9%) | -26.32%(+93.7%) |
Sep 2005 | - | -13.59%(-6008.7%) |
Jun 2005 | - | 0.23%(-97.0%) |
Mar 2005 | - | 7.63%(-36.3%) |
Dec 2004 | 11.97%(-278.7%) | 11.98%(+115.9%) |
Sep 2004 | - | 5.55%(+3164.7%) |
Jun 2004 | - | 0.17%(-80.5%) |
Mar 2004 | - | 0.87%(-104.6%) |
Dec 2003 | -6.70%(-122.1%) | -19.02%(-52.3%) |
Sep 2003 | - | -39.89%(+234.1%) |
Jun 2003 | - | -11.94%(+0.4%) |
Mar 2003 | - | -11.89%(-487.3%) |
Dec 2002 | 30.36%(-197.2%) | 3.07%(-37.9%) |
Sep 2002 | - | 4.94%(-115.0%) |
Jun 2002 | - | -32.95%(+13.3%) |
Mar 2002 | - | -29.09%(+14.7%) |
Dec 2001 | -31.25%(-36.2%) | -25.37%(-470.9%) |
Sep 2001 | - | 6.84%(+81.4%) |
Jun 2001 | - | 3.77%(-47.4%) |
Mar 2001 | - | 7.17%(-119.0%) |
Dec 2000 | -48.96%(-1.8%) | -37.83%(-44.2%) |
Sep 2000 | - | -67.85%(-24.2%) |
Jun 2000 | - | -89.53%(-20.1%) |
Mar 2000 | - | -112.11%(+152.6%) |
Dec 1999 | -49.86%(+2.3%) | -44.39%(-24.9%) |
Sep 1999 | - | -59.12%(+7.8%) |
Jun 1999 | - | -54.82%(+17.3%) |
Mar 1999 | - | -46.74%(-22.1%) |
Dec 1998 | -48.76%(+34.1%) | -60.01%(+26.4%) |
Sep 1998 | - | -47.47%(-10.3%) |
Jun 1998 | - | -52.92%(-15.4%) |
Mar 1998 | - | -62.58%(+11.8%) |
Dec 1997 | -36.36%(+21.7%) | -55.99%(+54.0%) |
Sep 1997 | - | -36.36%(+21.7%) |
Jun 1997 | - | -29.87%(-2.8%) |
Mar 1997 | - | -30.74%(-51.9%) |
Dec 1996 | -29.87% | -63.89%(-118.1%) |
Sep 1996 | - | 353.33%(+35.9%) |
Jun 1996 | - | 260.00%(+160.0%) |
Mar 1996 | - | 100.00% |
FAQ
- What is Avadel Pharmaceuticals plc annual return on equity?
- What is the all time high annual ROE for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual ROE year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly return on equity?
- What is the all time high quarterly ROE for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?
What is Avadel Pharmaceuticals plc annual return on equity?
The current annual ROE of AVDL is -60.44%
What is the all time high annual ROE for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual return on equity is 113.79%
What is Avadel Pharmaceuticals plc annual ROE year-on-year change?
Over the past year, AVDL annual return on equity has changed by +420.91% (+87.44%)
What is Avadel Pharmaceuticals plc quarterly return on equity?
The current quarterly ROE of AVDL is -3.81%
What is the all time high quarterly ROE for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly return on equity is 755.56%
What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?
Over the past year, AVDL quarterly return on equity has changed by +104.64% (+96.49%)